This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Review paper

Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies

Volume: 39, Issue: 12, Pages: 4547 - 4554
Published: Jun 13, 2020
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease 19 (COVID-19), is a novel human Coronavirus that is responsible for about 300,000 deaths worldwide. To date, there is no confirmed treatment or vaccine prevention strategy against COVID-19. Due to the urgent need for effective treatment, drug repurposing is regarded as the immediate option. Potential drugs can often be identified via in...
Paper Details
Title
Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies
Published Date
Jun 13, 2020
Volume
39
Issue
12
Pages
4547 - 4554
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.